Partner Headlines - ESRX

  1. Horizon Pharma Up On Bullish Leerink Initiation

    IBD
  2. CVS Health Buys Omnicare, Citing 'Long-Term' Benefits

    IBD
  3. Drug 'super spending' soars

    IBD
  4. 20 Questions With David Rolfe Part I

    GuruFocus
  5. Addiction Care Provider AAC Eyes National Brand

    IBD
  6. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD
  7. Regeneron Q1 Earnings Beat As Eylea Research Pays Off

    IBD
  8. GoPro, Other Earnings Trigger Wild Price Swings

    IBD
  9. EXPRESS SCRIPTS

    IBD
  10. Express Scripts Posts In-Line Q1 Earnings, Issues Strong Forecast

    Benzinga
  11. Stocks Stumble To Early Losses; IPG Photonics Jumps

    IBD
  12. Why CVS Health And McKesson May Be Good Stock Picks

    IBD
  13. UnitedHealth Profit Soars On ObamaCare, Optum

    IBD
  14. UnitedHealth Up After Topping Views, Raising Outlook

    IBD
  15. UnitedHealth Eyes Biggest Earnings Gain In Years

    IBD
  16. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD
  17. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD
  18. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD
  19. 10 Stocks You Should Be Watching Today

    Benzinga
  20. EXPRESS SCRIPTS

    IBD
  21. UPDATE: Express Scripts Tops Q4 Expectations, Shares Rise After ...

    Benzinga
  22. Nasdaq Stretches Win Streak To 9 Days

    IBD
  23. Earnings Scheduled For February 23, 2015

    Benzinga
  24. Must Watch Stocks for Today

    Benzinga
  25. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD
  26. Rolfe Adds One Company to Portfolio in Fourth Quarter

    GuruFocus
  27. Analyzing Needham Growth Fund's Pick: Express Scripts (ESRX)

    GuruFocus
  28. Analyzing Needham Growth Fund's Pick: CarMax (KMX)

    GuruFocus
  29. Rite Aid Stock Soars, Steps Up Competition With CVS

    IBD
  30. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's ...

    GuruFocus
  31. Thornburg Value Fund Q4 2014 Commentary

    GuruFocus
  32. Gilead Q4 Earnings Beat, But Price War Taking Toll

    IBD
  33. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga
  34. Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum ...

    Benzinga
  35. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD
  36. Has Gilead Sciences Been Able To Maintain Its Lead Run In The ...

    GuruFocus
  37. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD
  38. Why Drug Pricing Could Bring Volatility To The Biotech Sector ...

    Benzinga
  39. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD
  40. What The Market's Reading: An Iraq Ramp-Up & Biotech Moves

    Benzinga
  41. Steven Romick Buys 7 US and International Stocks in Q4

    GuruFocus
  42. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD
  43. Cholesterol Drug Costs Eyed

    IBD
  44. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus
  45. Amgen's Decline May Be Linked To Comments Of Express Script's ...

    Benzinga
  46. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  47. AbbVie Stock Down After Guidance, Downgrade

    IBD
  48. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus
  49. Hepatitis Drugs Vie For Share

    IBD
  50. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD
  51. Stocks Lose More Ground; Gilead Sciences Rises

    IBD
  52. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD
  53. Drug Distributor Reaps The Rewards Of Strategy Shift

    IBD
  54. Express Scripts Stock Dominated Q4; Which Funds Might've Won?

    Benzinga
  55. 5 Biotech Stocks With Big News Due In January

    IBD
  56. Stocks Hold Near Highs; LifeLock Breaks Out

    IBD
  57. Facebook Among IBD 50's Top 5 Earnings Kings In 2014

    IBD
  58. IBD 50: Biotechs Hammered, Then Find Support

    IBD
  59. First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases ...

    GuruFocus
  60. Biotech Stocks Take A Beating, But Find Support

    IBD
  61. Stocks Score Small Gains; Virgin America Takes Flight

    IBD
  62. How Gilead And Johnson & Johnson's Tumble Affected These Hedge ...

    Benzinga
  63. Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis ...

    Benzinga
  64. Toys, Department Stores Rock, But Biotechs Tumble

    IBD
  65. Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price ...

    Benzinga
  66. AbbVie Drug Displaces Gilead

    IBD
  67. Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive

    IBD
  68. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  69. Express Scripts Knocks Gilead's Hepatitis C Drug in Favor of ...

    GuruFocus
  70. Bank Of America Downgrades Gilead Sciences, Sees Possible Pricing ...

    Benzinga
  71. Broad Indexes Little Changed; Facebook Breaks Out

    IBD
  72. Dow Outperforms While Nasdaq Holds Small Gain; Oil Weak

    IBD
  73. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  74. Mid-Morning Market Update: Markets Open Higher; Caesars Entertainment ...

    Benzinga
  75. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  76. Gilead Sciences Plummets Amid AbbVie Deal With Express Scripts

    Benzinga
  77. Stock Futures Point Higher; AbbVie Surges, Gilead Dives

    IBD
  78. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD
  79. How Can Drugmakers Handle New Pricing Pressures?

    IBD
  80. Are These Drugstore Retailers Good Investments?

    GuruFocus
  81. AmerisourceBergen a Key Player in the Pharma Industry

    GuruFocus
  82. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus
  83. 5 Stock-Moving Medtech Events This December

    IBD
  84. Top 4 Stocks In The Health Care Plans Industry With The Highest ...

    Benzinga
  85. Surprisingly, Warren Buffett Buys These 8 Dividend Stocks

    GuruFocus
  86. Warren Buffett and CIOs Buy DirecTV, Charter Communications, ...

    GuruFocus
  87. Scour Mutual Fund Special Sections For Great Ideas

    IBD
  88. Buybacks-Driven Market: Engineered Too Far?

    YCharts
  89. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond ...

    Benzinga
  90. Express Scripts Posts EPS In-line With Estimates

    Benzinga
  91. Stocks Tack On Gains; Centene Hits New High

    IBD
  92. AmerisourceBergen's Move To Go Big Is The Right Rx

    IBD
  93. 2015 Express Scripts Medicare Prescription Drug Plans Earn CMS ...

    Benzinga
  94. These 3 Upcoming IPOs Have Strong Investor Interest

    IBD
  95. IPO Calendar: HubSpot, Dave & Buster's Among 8 IPOs

    IBD
  96. 2 Mutual Funds Holding Hospital Stocks

    Benzinga
  97. UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company

    Benzinga
  98. Benzinga's Top Downgrades

    Benzinga
  99. Goldman Sachs Downgrades Express Scripts To Neutral

    Benzinga
  100. Air Methods Navigates To Grow Medical Flight Business

    IBD
Trading Center